BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 102.50
-0.50 (-0.49%)
Jan 22, 2026, 12:49 PM CST
BIONET Market Cap
BIONET has a market cap or net worth of 5.18 billion as of January 21, 2026. Its market cap has increased by 27.22% in one year.
Market Cap
5.18B
Enterprise Value
4.76B
Revenue
1.22B
Ranking
n/a
PE Ratio
74.59
Stock Price
102.50
Market Cap Chart
Since November 3, 2008, BIONET's market cap has increased from 1.14B to 5.18B, an increase of 353.10%. That is a compound annual growth rate of 9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.18B | -0.48% |
| Dec 31, 2025 | 5.21B | 29.12% |
| Dec 31, 2024 | 4.03B | 47.30% |
| Dec 29, 2023 | 2.74B | 32.70% |
| Dec 30, 2022 | 2.06B | 9.73% |
| Dec 30, 2021 | 1.88B | -2.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 203.42B |
| Lotus Pharmaceutical | 79.95B |
| Heron Neutron Medical | 65.72B |
| SciVision Biotech | 5.79B |
| Locus Cell | 5.78B |
| Panion & Bf Biotech | 5.47B |
| UnicoCell Biomed | 5.33B |